BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32625199)

  • 1. A Novel Pathogenic Variant in
    Yonkof JR; Gupta A; Rueda CM; Mangray S; Prince BT; Rangarajan HG; Alshahrani M; Varga E; Cripe TP; Abraham RS
    Front Immunol; 2020; 11():884. PubMed ID: 32625199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CARMIL2 Immunodeficiency with Epstein Barr Virus Associated Smooth Muscle Tumor (EBV-SMT). Report of a Case with Comprehensive Review of Literature.
    Vij M; Sivasankaran M; Jayaraman D; Sankaranarayanan S; Kumar V; Munirathnam D; Scott J
    Fetal Pediatr Pathol; 2022 Dec; 41(6):1023-1034. PubMed ID: 34738861
    [No Abstract]   [Full Text] [Related]  

  • 3. Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency.
    Lévy R; Gothe F; Momenilandi M; Magg T; Materna M; Peters P; Raedler J; Philippot Q; Rack-Hoch AL; Langlais D; Bourgey M; Lanz AL; Ogishi M; Rosain J; Martin E; Latour S; Vladikine N; Distefano M; Khan T; Rapaport F; Schulz MS; Holzer U; Fasth A; Sogkas G; Speckmann C; Troilo A; Bigley V; Roppelt A; Dinur-Schejter Y; Toker O; Bronken Martinsen KH; Sherkat R; Somekh I; Somech R; Shouval DS; Kühl JS; Ip W; McDermott EM; Cliffe L; Ozen A; Baris S; Rangarajan HG; Jouanguy E; Puel A; Bustamante J; Alyanakian MA; Fusaro M; Wang Y; Kong XF; Cobat A; Boutboul D; Castelle M; Aguilar C; Hermine O; Cheminant M; Suarez F; Yildiran A; Bousfiha A; Al-Mousa H; Alsohime F; Cagdas D; Abraham RS; Knutsen AP; Fevang B; Bhattad S; Kiykim A; Erman B; Arikoglu T; Unal E; Kumar A; Geier CB; Baumann U; Neven B; ; Rohlfs M; Walz C; Abel L; Malissen B; Marr N; Klein C; Casanova JL; Hauck F; Béziat V
    J Exp Med; 2023 Feb; 220(2):. PubMed ID: 36515678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency.
    Kolukisa B; Baser D; Akcam B; Danielson J; Bilgic Eltan S; Haliloglu Y; Sefer AP; Babayeva R; Akgun G; Charbonnier LM; Schmitz-Abe K; Kendir Demirkol Y; Zhang Y; Gonzaga-Jauregui C; Jimenez Heredia R; Kasap N; Kiykim A; Ozek Yucel E; Gok V; Unal E; Pac Kisaarslan A; Nepesov S; Baysoy G; Onal Z; Yesil G; Celkan TT; Cokugras H; Camcioglu Y; Eken A; Boztug K; Lo B; Karakoc-Aydiner E; Su HC; Ozen A; Chatila TA; Baris S
    Allergy; 2022 Mar; 77(3):1004-1019. PubMed ID: 34287962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus
    Magg T; Schober T; Walz C; Ley-Zaporozhan J; Facchetti F; Klein C; Hauck F
    Front Immunol; 2018; 9():368. PubMed ID: 29535735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human immunodeficiency syndrome caused by mutations in CARMIL2.
    Schober T; Magg T; Laschinger M; Rohlfs M; Linhares ND; Puchalka J; Weisser T; Fehlner K; Mautner J; Walz C; Hussein K; Jaeger G; Kammer B; Schmid I; Bahia M; Pena SD; Behrends U; Belohradsky BH; Klein C; Hauck F
    Nat Commun; 2017 Jan; 8():14209. PubMed ID: 28112205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency.
    Alazami AM; Al-Helale M; Alhissi S; Al-Saud B; Alajlan H; Monies D; Shah Z; Abouelhoda M; Arnaout R; Al-Dhekri H; Al-Numair NS; Ghebeh H; Sheikh F; Al-Mousa H
    Front Immunol; 2018; 9():203. PubMed ID: 29479355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease.
    Bosa L; Batura V; Colavito D; Fiedler K; Gaio P; Guo C; Li Q; Marzollo A; Mescoli C; Nambu R; Pan J; Perilongo G; Warner N; Zhang S; Kotlarz D; Klein C; Snapper SB; Walters TD; Leon A; Griffiths AM; Cananzi M; Muise AM
    Sci Rep; 2021 Mar; 11(1):5945. PubMed ID: 33723309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.
    Shamriz O; Simon AJ; Lev A; Megged O; Ledder O; Picard E; Joseph L; Molho-Pessach V; Tal Y; Millman P; Slae M; Somech R; Toker O; Berger M
    Clin Exp Immunol; 2020 Jun; 200(3):215-227. PubMed ID: 32201938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel CARMIL2 (RLTPR) Mutation Presenting with Hyper-IgE and Eosinophilia: A Case Report.
    Zamani R; Zoghi S; Shahkarami S; Seyedpour S; Jimenez Heredia R; Boztug K; Rezaei N
    Endocr Metab Immune Disord Drug Targets; 2024; 24(5):596-605. PubMed ID: 37855284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells.
    Roncagalli R; Cucchetti M; Jarmuzynski N; Grégoire C; Bergot E; Audebert S; Baudelet E; Menoita MG; Joachim A; Durand S; Suchanek M; Fiore F; Zhang L; Liang Y; Camoin L; Malissen M; Malissen B
    J Exp Med; 2016 Oct; 213(11):2437-2457. PubMed ID: 27647348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Unique Presentation of Infantile-Onset Colitis and Eosinophilic Disease without Recurrent Infections Resulting from a Novel Homozygous CARMIL2 Variant.
    Kurolap A; Eshach Adiv O; Konnikova L; Werner L; Gonzaga-Jauregui C; Steinberg M; Mitsialis V; Mory A; Nunberg MY; Wall S; Shaoul R; Overton JD; ; Shuldiner AR; Zohar Y; Paperna T; Snapper SB; Shouval DS; Baris Feldman H
    J Clin Immunol; 2019 May; 39(4):430-439. PubMed ID: 31079270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potential founder variant in
    Sorte HS; Osnes LT; Fevang B; Aukrust P; Erichsen HC; Backe PH; Abrahamsen TG; Kittang OB; Øverland T; Jhangiani SN; Muzny DM; Vigeland MD; Samarakoon P; Gambin T; Akdemir ZH; Gibbs RA; Rødningen OK; Lyle R; Lupski JR; Stray-Pedersen A
    Mol Genet Genomic Med; 2016 Nov; 4(6):604-616. PubMed ID: 27896283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited TNFSF9 deficiency causes broad Epstein-Barr virus infection with EBV+ smooth muscle tumors.
    Fournier B; Hoshino A; Bruneau J; Bachelet C; Fusaro M; Klifa R; Lévy R; Lenoir C; Soudais C; Picard C; Blanche S; Castelle M; Moshous D; Molina T; Defachelles AS; Neven B; Latour S
    J Exp Med; 2022 Jul; 219(7):. PubMed ID: 35657354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-associated adrenal smooth muscle tumors and disseminated diffuse large B-cell lymphoma in a child with common variable immunodeficiency: a case report and review of the literature.
    Petrilli G; Lorenzi L; Paracchini R; Ubiali A; Schumacher RF; Cabassa P; Facchetti F
    Int J Surg Pathol; 2014 Dec; 22(8):712-21. PubMed ID: 21454372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations.
    Wang Y; Ma CS; Ling Y; Bousfiha A; Camcioglu Y; Jacquot S; Payne K; Crestani E; Roncagalli R; Belkadi A; Kerner G; Lorenzo L; Deswarte C; Chrabieh M; Patin E; Vincent QB; Müller-Fleckenstein I; Fleckenstein B; Ailal F; Quintana-Murci L; Fraitag S; Alyanakian MA; Leruez-Ville M; Picard C; Puel A; Bustamante J; Boisson-Dupuis S; Malissen M; Malissen B; Abel L; Hovnanian A; Notarangelo LD; Jouanguy E; Tangye SG; Béziat V; Casanova JL
    J Exp Med; 2016 Oct; 213(11):2413-2435. PubMed ID: 27647349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
    Magg T; Shcherbina A; Arslan D; Desai MM; Wall S; Mitsialis V; Conca R; Unal E; Karacabey N; Mukhina A; Rodina Y; Taur PD; Illig D; Marquardt B; Hollizeck S; Jeske T; Gothe F; Schober T; Rohlfs M; Koletzko S; Lurz E; Muise AM; Snapper SB; Hauck F; Klein C; Kotlarz D
    Inflamm Bowel Dis; 2019 Oct; 25(11):1788-1795. PubMed ID: 31115454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and Molecular Characteristics of Epstein-Barr Virus-Associated Smooth Muscle Tumor Compared With Those of Leiomyoma and Leiomyosarcoma.
    Wah NW; Mok Y; Omar N; Chang KTE; Tay TKY; Hue SS; Lee VKM
    Mod Pathol; 2023 Jun; 36(6):100127. PubMed ID: 36965331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus-associated smooth muscle tumor of the cavernous sinus: a delayed complication of allogenic peripheral blood stem cell transplantation: case report.
    Raheja A; Sowder A; Palmer C; Rodriguez FJ; Couldwell WT
    J Neurosurg; 2017 May; 126(5):1479-1483. PubMed ID: 27341041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility.
    Winter S; Martin E; Boutboul D; Lenoir C; Boudjemaa S; Petit A; Picard C; Fischer A; Leverger G; Latour S
    EMBO Mol Med; 2018 Feb; 10(2):188-199. PubMed ID: 29282224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.